Updated:
Apervita
Apervita is a Chicago-based family office investing in health-tech, analytics, and enterprise software. Its AUM and principals are not publicly disclosed.
Apervita
The founding year and wealth origin of Apervita are not a matter of public record. The firm's name and location point to a Chicago-based family office with a documented focus on health-technology investments, though no named principals or direct lineage to a specific family fortune have been confirmed in public sources. Apervita targets the healthcare technology sector with a strategy centered on analytics, data interoperability, and clinical workflow software. The firm's investment posture includes software platforms that enable value-based care, population health management, and regulatory compliance for providers and payers. Geographic focus appears to be primarily North America, with the majority of portfolio activity in the United States. No specific co-investors or named portfolio companies are publicly associated with the firm. No team size, additional office locations, or adjacent philanthropic vehicles are disclosed for Apervita. The firm has not publicly reported any operational events such as fund closings or leadership changes in the past 24 months. Apervita's structural differentiator is its vertical concentration in health-tech as a family office — a narrower focus than generalist single-family offices. Without public disclosures on governance or succession, the firm's architecture remains opaque to external allocators.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Chicago, IL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Apervita?
The principals and investment decision-makers at Apervita have not been publicly named. No CEO, CIO, or managing principal is listed in public records, and the firm does not maintain a public website or LinkedIn presence that identifies its leadership. This lack of disclosure is unusual even among private family offices.
How does Apervita source deal flow?
Apervita likely relies on proprietary networks in the health-tech and healthcare analytics sectors, given its Chicago location and vertical focus. No public information is available on its sourcing model. The firm may participate in direct deals or co-investments, but no known partnerships or deal leads have been documented in public sources.
Is Apervita a single family office or a multi-family office?
Apervita is presumed to be a single family office based on its naming pattern and lack of multiple family references in public records. However, this classification is not confirmed by any official filing or disclosure. The firm does not operate a public website or regulatory filings that clarify its structure.
Does Apervita participate in fund commitments or only direct deals?
No public information specifies whether Apervita makes fund commitments or invests solely through direct deals. Its disclosed focus on health-tech suggests a preference for direct control and operational alignment, but this is speculative. The absence of public data means allocators cannot verify its investment vehicle preferences.
What investment stages does Apervita typically target?
Apervita's stage target is not disclosed in any public source. Its focus on health-tech analytics and enterprise software could align with growth-stage or late-stage investments, but this is not confirmed. The firm may also pursue early-stage direct investments, but no public portfolio data exists to confirm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: